Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAABS Protocol: Weight Loss Meds Post-Sleeve Gastrectomy
NCT04572217Phase 2Withdrawn
- Start
- Jun 2022
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of topiramate and phentermine in pediatric obesity (2 arms). Primary endpoint: Number of participants who are able to consent for off-label medication use at 1 year. Planned start Jun 2022; status: withdrawn.
02
Drugs
topiramatephentermine
03
Conditions
pediatric obesity
Beyond the preview
Go deeper on NCT04572217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04572217.